AnaptysBio
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AnaptysBio and other ETFs, options, and stocks.About ANAB
AnaptysBio, Inc. is a clinical-stage biotechnology company, which engages in delivering innovative immunology therapeutics for autoimmune and inflammatory diseases. The firm’s product pipeline includes Rosnilimab, ANB033, ANB101, Jemperli, and Imsidolimab.
ANAB Key Statistics
Stock Snapshot
As of today, AnaptysBio(ANAB) shares are valued at $45.43. The company's market cap stands at 1.36B, with a P/E ratio of 7.64.
On 2026-10-20, AnaptysBio(ANAB) stock traded between a low of $44.02 and a high of $51.85. Shares are currently priced at $45.43, which is +3.2% above the low and -12.4% below the high.
AnaptysBio(ANAB) shares are trading with a volume of 1.21M, against a daily average of 502.41K.
During the past year, AnaptysBio(ANAB) stock moved between $22.17 at its lowest and $72.36 at its peak.
During the past year, AnaptysBio(ANAB) stock moved between $22.17 at its lowest and $72.36 at its peak.
ANAB News
Advertisement Jemperli approval puts AnaptysBio back in focus GSK’s new FDA approval for Jemperli in MSI-H/dMMR locally advanced rectal cancer has pushed Anap...
AnaptysBio (ANAB), a company focused on managing the financial collaborations for Jemperli with Tesaro, a GSK (GSK) company, and Quimilza with Vanda, announced...
Analyst ratings
100%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.